![Loading Events](https://abliva.com/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
- This event has passed.
Mitocon’s Mitochondrial Diseases Conference
7 October, 2022 - 8 October, 2022
![](https://abliva.com/wp-content/uploads/2022/08/Rome_Colosseo.jpeg)
In October, Abliva will attend the Italian patient organization Mitocon’s annual Mitochondrial Diseases Conference in Rome, Italy.
On October 8, Abliva’s Chief Medical Officer Magnus Hansson will give the talk: An adaptive, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical trials design – presentations and round table discussion.